Transcriptomics

Dataset Information

0

BRAF V600E mutant colorectal cancer subtypes based on gene expression

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE75317 | GEO | 2016/11/28

SECONDARY ACCESSION(S): PRJNA303175

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics BRAF V600E mutant colorectal cancer subtypes based on gene expression
| PRJNA303175 | ENA
Unknown CK7 and consensus molecular subtypes as major prognosticators in <sup>V600E</sup>BRAF mutated metastatic colorectal cancer.
| S-EPMC6889398 | biostudies-literature
Unknown The Evolutionary Landscape of Treatment for <i>BRAF<sup>V600E</sup></i> Mutant Metastatic Colorectal Cancer.
| S-EPMC7795863 | biostudies-literature
Unknown Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.
| S-EPMC5551390 | biostudies-literature
Unknown Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
| S-EPMC7260582 | biostudies-literature
Unknown Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.
| S-EPMC4001781 | biostudies-literature
Genomics Human dermal fibroblasts (HDF), BRAF-V600E positive (MaMel21 and MaMel63a), and BRAF-WT malignant melanoma cell lines (SBcl2 and WM3438) after vemurafenib or DMSO treatment
2021-12-11 | GSE188470 | GEO
Transcriptomics Molecular Subtypes in Head and Neck Cancer
2013-03-01 | E-GEOD-39368 | biostudies-arrayexpress
Transcriptomics Expression profiling of V600E BRAF and RTK-activated cells upon MEK inhibition
2009-02-11 | GSE10086 | GEO
Unknown Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational model.
| S-EPMC5460205 | biostudies-literature